CINECA IRIS Institutional Research Information System

ANTONIOLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.335
AS - Asia 7.492
EU - Europa 6.455
SA - Sud America 1.134
AF - Africa 385
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 5
Totale 30.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.919
IT - Italia 2.540
SG - Singapore 2.434
CN - Cina 1.966
HK - Hong Kong 1.225
BR - Brasile 950
SE - Svezia 825
VN - Vietnam 641
DE - Germania 570
BG - Bulgaria 452
GB - Regno Unito 380
FI - Finlandia 323
FR - Francia 289
CA - Canada 277
TR - Turchia 277
RU - Federazione Russa 271
AT - Austria 256
IN - India 209
JP - Giappone 165
CI - Costa d'Avorio 148
UA - Ucraina 123
KR - Corea 107
NL - Olanda 106
MX - Messico 78
PL - Polonia 75
AR - Argentina 72
CH - Svizzera 64
IQ - Iraq 63
PK - Pakistan 62
BD - Bangladesh 61
BE - Belgio 46
SN - Senegal 46
UZ - Uzbekistan 39
ZA - Sudafrica 38
ID - Indonesia 37
NG - Nigeria 37
ES - Italia 29
VE - Venezuela 29
IR - Iran 26
MA - Marocco 26
SA - Arabia Saudita 26
EC - Ecuador 25
AU - Australia 24
EG - Egitto 22
CO - Colombia 20
PH - Filippine 20
KE - Kenya 17
CZ - Repubblica Ceca 16
AE - Emirati Arabi Uniti 15
LT - Lituania 14
PY - Paraguay 14
AZ - Azerbaigian 13
MY - Malesia 13
TW - Taiwan 13
DZ - Algeria 11
IE - Irlanda 11
JM - Giamaica 11
PT - Portogallo 11
TN - Tunisia 11
CL - Cile 10
IL - Israele 9
JO - Giordania 9
LB - Libano 9
PA - Panama 9
NO - Norvegia 8
AL - Albania 7
BJ - Benin 7
HN - Honduras 7
KZ - Kazakistan 7
OM - Oman 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
HU - Ungheria 6
KG - Kirghizistan 6
PE - Perù 6
RS - Serbia 6
UY - Uruguay 6
BY - Bielorussia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
RO - Romania 5
CG - Congo 4
DK - Danimarca 4
GD - Grenada 4
GH - Ghana 4
GR - Grecia 4
NP - Nepal 4
QA - Qatar 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AO - Angola 3
BS - Bahamas 3
CR - Costa Rica 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
LV - Lettonia 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
TH - Thailandia 3
Totale 30.805
Salva come PNG Salva come JPEG
Città #
Ashburn 1.596
Singapore 1.340
Fairfield 1.262
Hong Kong 1.186
Woodbridge 1.175
Dallas 998
Ann Arbor 940
San Jose 857
Houston 848
Santa Clara 787
Chandler 782
Seattle 498
Wilmington 480
Cambridge 448
Sofia 446
Shanghai 440
Milan 409
Beijing 399
Serra 376
New York 333
Boardman 264
Los Angeles 240
Princeton 192
Ottawa 190
Pisa 174
Vienna 174
Lawrence 168
Lauterbourg 161
Council Bluffs 153
Medford 150
Abidjan 148
Florence 148
Tokyo 137
Ho Chi Minh City 132
Izmir 131
Helsinki 121
Munich 121
Jacksonville 119
Hefei 118
Dong Ket 116
Hanoi 112
Des Moines 109
Rome 106
London 105
Istanbul 93
Nanjing 93
Frankfurt am Main 90
Chicago 88
Seoul 86
São Paulo 84
Bremen 81
Buffalo 81
Redondo Beach 74
Dearborn 73
Turku 57
Lucca 55
Lappeenranta 50
Nanchang 49
Dakar 46
Warsaw 46
Columbus 44
Lancaster 44
Ogden 44
Brussels 43
San Diego 41
Redwood City 40
Falls Church 39
The Dalles 36
Tashkent 35
Lagos 34
Atlanta 32
Chennai 32
Nuremberg 32
Washington 32
Boulder 29
Toronto 29
Zurich 29
Bern 28
Orem 28
Montignoso 27
Phoenix 27
Pune 27
Rio de Janeiro 27
Guangzhou 26
Montreal 26
Bologna 25
Naples 25
Livorno 24
Tianjin 24
Changsha 23
Kunming 23
Marseille 23
Amsterdam 22
Fuzhou 22
Hebei 22
Da Nang 21
Porto Alegre 21
Baghdad 20
Belo Horizonte 20
Brooklyn 20
Totale 21.501
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 533
Preparation of isoindoline derivatives for use as AMPK activators 341
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 304
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 279
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 271
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 270
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 270
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 265
Derivati benzofuranici come attivatori di AMPK 250
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 249
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 229
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 229
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 225
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 225
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 224
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 216
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 213
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 210
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 210
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 208
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 208
CD39 and CD73 in immunity and inflammation 205
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 203
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 202
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 198
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 198
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 197
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 196
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 196
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 195
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 195
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 194
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 194
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 194
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 193
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 193
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 192
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 192
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 192
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 191
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 190
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 190
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 189
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 188
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 188
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 184
Role of A2a adenosine in the regulation of colonic motility in normal human colon 183
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 183
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 183
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 183
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 183
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 182
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 181
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 180
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 180
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 179
Preparation of benzofuran derivatives for use as AMPK activators 179
Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases 179
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 177
Donepezil improves vascular function in a mouse model of Alzheimer's disease 176
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 175
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 175
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 175
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 174
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 174
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 173
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 173
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 172
Allopurinol adherence among patients with gout: an Italian general practice database study 170
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 169
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 169
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 169
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 168
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 168
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 168
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 167
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 167
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 166
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 166
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 165
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 164
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 164
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 161
Transient acute liver failure complicating transurethral resection syndrome 161
Adenosine and inflammation: what's new on the horizon? 160
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 159
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 159
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 159
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 157
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 157
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 157
Risankizumab for the treatment of moderate to severe psoriasis 156
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 154
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 154
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 154
Anti-CD73 in cancer immunotherapy: awakening new opportunities 154
The intestinal barrier in disorders of the central nervous system 153
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 153
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 153
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 152
Totale 19.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021418 0 0 0 0 0 0 0 0 0 0 106 312
2021/20222.056 37 87 66 105 390 307 74 115 127 86 138 524
2022/20232.925 334 398 220 282 285 387 37 229 479 49 190 35
2023/20242.469 221 223 285 193 360 427 63 115 106 96 132 248
2024/20256.733 82 252 109 397 552 730 649 299 735 864 710 1.354
2025/20267.926 532 896 1.093 724 855 669 1.287 420 548 817 85 0
Totale 31.614